BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 20, 2008
View Archived Issues
Neurim Pharmaceuticals reports positive results with Neu-164 in experimental asthma and COPD
Read More
First-in-class protein kinase D inhibitor shows preclinical anticancer activity
Read More
New agents for metabolic disorders disclosed in recent patents
Read More
RNase L may be involved in the mode of action of lopinavir against HPV
Read More
Cellular assays with vorinostat in combination with conventional chemotherapy for SCLC
Read More
Recent Auspex patent reports novel anti-HIV agents
Read More
Recent patents impart new anticancer agents
Read More
Genentech reports progress of third quarter
Read More
FDA to review Targanta's NDA for oritavancin in cSSSI in November 2008
Read More
Epigenomics reports positive results from prognostic prostate cancer study
Read More
Tibotec enrolls patients in phase III telaprevir study in HCV
Read More
FDA approves Astepro for allergic rhinitis
Read More
Biothera initiates dosing in second arm of trial of Imprime PGG in mCRC
Read More
Pirfenidone approved in Japan for idiopathic pulmonary fibrosis
Read More
Exelixis submits diligence report to Bristol-Myers Squibb for Cdc7 inhibitor XL-413
Read More
AstraZeneca and Columbia University sign research collaboration in depression and anxiety
Read More
Cell Genesys terminates VITAL-1 trial of GVAX for prostate cancer and reports results from VITAL-2
Read More
WHO grants prequalified status to malaria drug Coarsucam
Read More
Jennerex completes treatment for first patient cohort in phase I clinical trial of JX-594
Read More
FDA approves Immutep's IND for phase I trial of ImmuFact in advanced pancreatic cancer
Read More
Alexza completes enrollment in second phase III AZ-004 trial
Read More
Australian TGA grants marketing approval to Abraxane in metastatic breast cancer
Read More
Celgene and Acceleron initiate phase II ACE-011 study
Read More
Daiichi Sankyo and Lilly respond to speculation about prasugrel NDA
Read More
Santen receives Japanese approval for Tapros in glaucoma and ocular hypertension
Read More
e-Therapeutics reports positive results from phase IIa clinical trial of ETX-9101 in asthma
Read More